» Articles » PMID: 31424714

Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab

Overview
Specialty Dermatology
Date 2019 Aug 20
PMID 31424714
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Guttate psoriasis is an acute subtype of plaque psoriasis characterized by eruption of small, scaly plaques, and papules, 5 to 10 mm in size over the trunk and proximal extremities.1 It often arises in children and young adults concomitantly with or shortly after a streptococcal throat infection or tonsillitis. Patients with chronic plaque psoriasis can also experience guttate flares following streptococcal throat infections.1,2 Controlling guttate psoriasis with topical corticosteroids is difficult to achieve due to numerous widespread lesions. Other treatment options include phototherapy and short term use of cyclosporine or methotrexate, as guttate variants of psoriasis can remit with these treatments.1,2 Guselkumab, an inhibitor of the p19 cytokine subunit of interleukin-23 and interleukin-39, produces dramatic resolutions of plaque psoriasis with long lasting effects.3 This case report describes a patient with a guttate variant of plaque psoriasis that resolved after a single administration of guselkumab and continues to remain clear more than 6 months after treatment with guselkumab.

Citing Articles

Guselkumab - In Psoriasis and Beyond.

Bubna A, Viplav V Dermatol Pract Concept. 2024; 14(3).

PMID: 39122539 PMC: 11314551. DOI: 10.5826/dpc.1403a181.


Management of Guttate Psoriasis: A Systematic Review.

Zhou T, Koussiouris J, Kim L, Vender R J Cutan Med Surg. 2024; 28(6):577-584.

PMID: 39080843 PMC: 11619194. DOI: 10.1177/12034754241266187.


Childhood guttate psoriasis: an updated review.

Leung A, Barankin B, Lam J, Leong K Drugs Context. 2023; 12.

PMID: 37908643 PMC: 10615329. DOI: 10.7573/dic.2023-8-2.


Rapid Remission of Sunburn-Induced Guttate Psoriasis with Guselkumab.

Bartholomew E, Chung B, Davis M, Yeroushalmi S, Chung M, Hakimi M Dermatol Ther (Heidelb). 2023; 13(10):2473-2478.

PMID: 37676470 PMC: 10539232. DOI: 10.1007/s13555-023-01013-y.


Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data.

Ruggiero A, Megna M, Fabbrocini G, Ocampo-Garza S Immunol Res. 2023; 71(3):328-355.

PMID: 36598647 PMC: 9811885. DOI: 10.1007/s12026-022-09356-y.